Nebenwirkungen · Zarzio
Zarzio 30 MU/0.5 mL solution for injection or infusion in pre-filled syringe Zarzio 48 MU/0.5 mL solution for injection or infusion in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 16
HOS-119849 · Präparat HOS-095029
No overall differences in safety or effectiveness were observed between subjects over 65 years of age compared to younger adult (> 18 years of age) subjects receiving cytotoxic chemotherapy and clinical experience has not identified differences in the responses between elderly and younger adult patients. There is insufficient data to evaluate filgrastim use in geriatric subjects for other approved filgrastim indications.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-22T12:00:00Z · SHA-256 33ebc5035d693fcece6fbad1099bd9e5461fbfda52d5dcdcea5065e4c020496c · Passage bea7eefa8d5b56a0d9f3395ec36ad6ad7ae7ff00aeee49e840841db7104e659c · Zeichen 10439–10863 im Abschnitt